Overview Financials News + Filings Key Docs Ownership Insiders
|
In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
Revenues | 1.0 | 2.9 | 0.7 | 1.6 | 0.8 | 1.7 | 0.1 | |
Revenue growth | -39.0% | 70.8% | 1056.0% | | | | | |
Cost of goods sold | 0.9 | 1.7 | 0.0 | 0.4 | 0.0 | 0.8 | 0.0 | |
Gross profit | 0.1 | 1.2 | 0.7 | 1.2 | 0.8 | 1.0 | 0.1 | |
Gross margin | 7.2% | 41.0% | 100.0% | 72.7% | 100.0% | 56.0% | 100.0% | |
Selling, general and administrative [+] | 1.0 | 1.7 | 1.1 | 1.6 | 1.2 | 1.5 | 0.3 | |
General and administrative | | 1.7 | | | | 1.5 | | |
EBIT [+] | -0.9 | -0.5 | -0.4 | -0.4 | -0.4 | -0.5 | -0.3 | |
EBIT growth | 107.5% | 2.7% | 52.8% | | 4415.3% | | | |
EBIT margin | -92.8% | -17.1% | -55.7% | -27.3% | -50.7% | -28.4% | -421.5% | |
Interest income | | 0.0 | | | | | | |
Interest income | | 0.0 | | | | | | |
Other income (expense), net [+] | 1.0 | 1.7 | 1.1 | 1.6 | 1.2 | 1.5 | 0.3 | |
Change in fair value of warrants | 0.6 | 0.4 | 0.4 | 1.4 | 1.3 | 1.4 | 0.8 | |
Pre-tax income | 0.1 | 1.2 | 0.7 | 1.2 | 0.8 | 1.0 | 0.1 | |
Income taxes | 0.1 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
Tax rate | 136.7% | 26.3% | 18.2% | 0.0% | 0.0% | 0.0% | 0.0% | |
Net income | 0.0 | 0.9 | 0.6 | 1.2 | 0.8 | 1.0 | 0.1 | |
Net margin | -2.7% | 30.2% | 81.8% | 72.7% | 100.0% | 56.0% | 100.0% | |
|
Basic EPS [+] | $0.00 | $0.23 | $0.03 | $0.06 | $0.04 | $0.25 | $0.01 | |
Growth | -104.7% | -10.6% | 440.6% | | -1745.8% | | | |
Diluted EPS [+] | $0.00 | $0.04 | $0.01 | $0.06 | $0.04 | $0.10 | $0.00 | |
Growth | -104.7% | -54.5% | 440.6% | | -1745.8% | | | |
|
Shares outstanding (basic) [+] | 9.7 | 3.9 | 20.3 | 20.3 | 20.3 | 3.8 | 11.6 | |
Growth | -52.2% | 3.1% | 75.0% | | 441.3% | | | |
Shares outstanding (diluted) [+] | 9.7 | 20.3 | 40.6 | 20.3 | 20.3 | 10.0 | 23.2 | |
Growth | -52.2% | 102.6% | 75.0% | | 441.3% | | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|